July 28, 2026 – The Government of Alberta has officially launched Canada’s first private-pay preventative diagnostic testing framework, allowing Albertans to purchase select diagnostic imaging services without a physician referral. The initiative, enabled through Bills 11 and 29, takes effect July 31, 2026 and represents a significant policy shift toward expanding private healthcare options while maintaining publicly-funded, medically necessary care.
For health organizations, diagnostic providers, MedTech companies and investors, Alberta is positioning itself as the first Canadian jurisdiction to create a regulated private preventative screening market.
Santis Insights
- Initial Rollout is Narrowly Focused: The government is focusing initial efforts on cancer-related preventative imaging. While additional designated tests are expected through future Ministerial Orders, this phased approach will allow the government and the system to better understand and handle demand, while targeting a key health priority.
- Workforce Resources Could Become Increasingly Strained: While the government is adamant that physician-referred testing will be prioritized – whether performed at a public or a private facility – a sharp increase in demand on diagnostic services could increase pressure on an already strained system.
- Tensions with Alberta’s Physicians on Policy: Alberta Medical Association President Dr. Brian Wirzba has criticized the province’s self-referral policy, warning that it could “further burden the public system” by generating unnecessary testing and follow-up care.
- Private Insurers will Face Increased Costs: In cases where a self-referred test leads to a new cancer diagnosis, the patient may qualify to have some or all of the cost reimbursed by the province, up to limits set by the government. However, the government has implemented a requirement that patients with private insurance must submit a claim to their insurer first, and the province will act as the payor of last resort. This issue could become divisive with insurers depending on the costs and frequency of uptake, particularly as debate continues around the legality of this policy under the Canada Health Act.
- Policy Likely to Face Legal Scrutiny: The policy is expected to remain highly divisive and legal challenges under the Canada Health Act are likely. While supporters view it as an expansion of patient choice and improvements to early detection, critics argue it shifts the province closer to a two-tier health care system. There will be increased pressure on the federal government to make a determination as to whether this violates the requirements of the Act, and whether they will make deductions under the Canada Health Transfer accordingly.
- A National Bellwether for Private Expansion: Other provinces will likely be monitoring this rollout to gauge federal pushback under the Canada Health Act, potential workforce impacts and the precedents set by private insurers.
- Strategic Positioning for the Province: Alberta’s policy framework signals a deliberate strategy to attract health care innovation by differentiating its regulatory landscape from other Canadian jurisdictions. This creates new potential for private-sector expansion in digital health, diagnostics, and preventative care. As the legislative framework unfolds, commercial entities will likely monitor legislative updates to gauge the long-term impact on market dynamic and public-private partnership models.
Key Details of Announcement
Effective July 31, 2026, Albertans will be able to purchase select diagnostic imaging services, including MRI, CT scans, X-rays and Ultrasounds. The provincial reimbursement process for eligible cancer-related claims is scheduled to begin August 1, 2026.
Policy Shifts
- Effective July 31, 2026, Albertans will be permitted to purchase select diagnostic imaging services out-of-pocket, specifically MRIs, CT scans, X-rays, and Ultrasounds.
- The government has mandated that traditional, physician-referred diagnostic testing will continue to be prioritized within the public system.
Patient Pathway and Reimbursement
- While no physician referral is required, patients cannot simply demand a test. A regulated health professional must first determine that the self-referred test is clinically appropriate and safe, and they retain the authority to decline the request, modify it, or recommend an alternative procedure.
- The province will launch a reimbursement process for eligible cancer-related claims on August 1, 2026. If a patient is diagnosed with a previously unknown cancer through one of these preventative screenings, they may receive reimbursement for the test at public rates, provided the claim is submitted within one year of the diagnosis.
- Patients who require follow-up care following a positive result will be formally transitioned into Cancer Care Alberta.
- To ensure continuity of care, all diagnostic results generated by these private clinics will be integrated directly into Alberta’s electronic health record (EHR) system.
Corresponding Public Investments
To support the broader health care system alongside this private market expansion, the announcement was paired with several significant public cancer care investments:
- $280 million dedicated to diagnostic imaging and cancer care infrastructure.
- $223 million allocated over three years for oncology services, surgeries, and facility upgrades.
- $5.5 million directed toward new cancer screening initiatives.
- $2.25 million to establish a provincial oncofertility program
Public Perception
A recent Santis-Nanos survey showed Canadians are supportive of at least some role for private care. However, there is a distinct preference for publicly funded, privately delivered services, with the bulk of the country still largely uncomfortable with direct, privately delivered services.
The announcement is likely to remain politically divisive. Supporters view the initiative as an innovative way to expand patient choice and improve early detection, while critics argue it represents another step toward a two-tier healthcare system and may increase pressure on Alberta’s public healthcare workforce. The policy will likely continue to attract significant media attention and stakeholder scrutiny as implementation begins.
The Opposition New Democratic Party (NDP) has been highly critical of the policy shift, accusing the government of “[taking] another step in dismantling health care” in the province. The NDP is treating the policy as a key point of dissent from the government, setting the stage for this to be a significant topic of conversation as Alberta moves towards a 2027 election.
Outlook
Alberta continues to try and position itself as Canada’s most innovative jurisdiction for healthcare delivery and private-sector participation. While the initial program is fairly limited, it establishes the legislative framework for future expansion into additional preventative health testing.
The success of Alberta’s expanded private diagnostic testing model will hinge on whether it genuinely creates additional capacity through net-new health professional recruitment, private investment and sufficient clinic participation without drawing scarce personnel away from the public system. Its reach and commercial viability will also depend on provider participation beyond major urban centres, consumer demand, and uptake by private insurers and employer benefit plans. Over the longer term, sustainability will require clear clinical safeguards, integrated reporting and follow-up pathways, and a stable reimbursement framework that prevents costs and care obligations from simply being shifted back to the public system.
Companies with interests in diagnostics, imaging, health technology, digital health, interoperability, insurance or preventative care should closely monitor forthcoming regulations and identify partnership opportunities as participating clinics begin operations starting July 31.